ABVC BioPharma (ABVC)

• Market cap: $69.7M
• 1 day: 5.71%
• 5 days: 2.78%
• 1 month: -1.33%
• 3 months: -7.5%
• 6 months: 164.29%
• Year to date: 361.56%
• 1 year: 368.87%
• 5 years: -90.1%
• 10 years: -90.1%
• Sector: Healthcare
• Industry: Biotechnology

About: ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.

Employees: 19